List of serched triples

A total of 22252 records found

#15552 middle Confidence
Subject: brain (Anatomical location)
is
Object: second_most_common_site_of_metastasis (Tumor metastasis site)
Original: brain#is#second most common site of metastasis
🏥 not_specified 📄 PMID: 38103326
#15551 middle Confidence
Subject: lymph_nodes (Anatomical location)
are
Object: most_common_site_of_metastasis (Tumor metastasis site)
Original: lymph nodes#are#most common site of metastasis
🏥 not_specified 📄 PMID: 38103326
#15550 middle Confidence
Subject: systematic_review (Research Methods)
describes
Object: clinicopathologic_features_of_PGM (Disease phenotype)
Original: A systematic review#describes#clinicopathologic features of PGM
🏥 Diagnostic significance 📄 PMID: 38103326
#15549 middle Confidence
Subject: MRT_of_the_liver (Neoplastic diseases)
reported_in
Object: English_literature (Literature reports)
Original: Eighteen cases of MRT of the liver#were published in#English literature
🏥 not_specified 📄 PMID: 15260854
#15548 middle Confidence
Subject: epithelioid_rhabdomyosarcoma (Tumor type)
metastasizes_to
Object: lymph_node (organize)
Original: A biopsy#encountered#epithelioid rhabdomyosarcoma with lymph node metastasis
🏥 Poor prognosis 📄 PMID: 26208724
#15547 middle Confidence
Subject: CD43 (Cell surface molecules)
serves_as
Object: diagnostic_marker_for_SCLC (Diagnostic markers)
Original: This report#highlights#a potential diagnostic pitfall in the diagnosis of SCLC/ urges caution in cases of LCA and CD43 positivity
🏥 Diagnostic significance 🧬 CD43 📄 PMID: 38649942
#15546 middle Confidence
Subject: ETV6 (Transcription Factors)
shows_split_signals_in
Object: nuclei (Nucleus)
Original: A fluorescence in situ hybridization study#revealed#split signals in the nuclei in all 3 cases
🏥 diagnosis 🧬 ETV6 📄 PMID: 34991563
#15545 middle Confidence
Subject: high-grade_transformed_SCs (Adenoid cystic carcinoma high-grade subtype)
develop
Object: distant_metastasis (Disease progression)
Original: High-grade transformed SCs#developed#locoregional recurrence and distant metastasis
🏥 Prognosis 📄 PMID: 34991563
#15544 middle Confidence
Subject: high-grade_transformed_SCs (Adenoid cystic carcinoma high-grade subtype)
develop
Object: locoregional_recurrence (Disease progression)
Original: High-grade transformed SCs#developed#locoregional recurrence and distant metastasis
🏥 Prognosis 📄 PMID: 34991563
#15543 middle Confidence
Subject: SCs (Adenoid cystic carcinoma cell)
demonstrate
Object: aggressive_clinical_features (Disease phenotype)
Original: A small subset of SCs#demonstrates#aggressive clinical features with histologically high-grade transformed morphology
🏥 Prognosis 📄 PMID: 34991563
#15542 middle Confidence
Subject: tumor (Tumor tissue)
expands
Object: morphologic_spectrum_of_Ewing_sarcoma (Disease phenotype)
Original: The tumor#extends#the morphologic spectrum of Ewing sarcoma beyond previously described histological variants
🏥 diagnosis 📄 PMID: 31585812
#15541 middle Confidence
Subject: tumor (Tumor)
shows
Object: melan-A_negative_immunoprofile (melan-A negative immunophenotype)
Original: tumors#showed#S100/SOX10-positive and HMB45/melan-A-negative immunoprofile
🏥 diagnosis 🧬 S100/SOX10/HMB45/melan-A 📄 PMID: 35039897
#15540 middle Confidence
Subject: tumor (Tumor)
shows
Object: HMB45_negative_immunoprofile (HMB45-negative immunophenotype)
Original: tumors#showed#S100/SOX10-positive and HMB45/melan-A-negative immunoprofile
🏥 diagnosis 🧬 S100/SOX10/HMB45/melan-A 📄 PMID: 35039897
#15539 middle Confidence
Subject: tumor (Tumor)
shows
Object: SOX10_positive_immunoprofile (SOX10-positive immunophenotype)
Original: tumors#showed#S100/SOX10-positive and HMB45/melan-A-negative immunoprofile
🏥 diagnosis 🧬 S100/SOX10/HMB45/melan-A 📄 PMID: 35039897
#15538 middle Confidence
Subject: tumor (Tumor)
shows
Object: S100_positive_immunoprofile (S100 positive immunophenotype)
Original: tumors#showed#S100/SOX10-positive and HMB45/melan-A-negative immunoprofile
🏥 diagnosis 🧬 S100/SOX10/HMB45/melan-A 📄 PMID: 35039897
#15537 middle Confidence
Subject: PLC (Tumor subtype)
was_more_frequently
Object: Ki-67_greater_than_10_percent (Proliferation markers)
Original: PLC#was more frequently#grade III/ estrogen receptor negative/ and had Ki-67 greater than 10% compared with classic ILC
🏥 Prognostic significance 📄 PMID: 22197540
#15536 middle Confidence
Subject: PLC (Tumor subtype)
was_more_frequently
Object: estrogen_receptor_negative (Molecular phenotype)
Original: PLC#was more frequently#grade III/ estrogen receptor negative/ and had Ki-67 greater than 10% compared with classic ILC
🏥 Prognostic significance 📄 PMID: 22197540
#15535 middle Confidence
Subject: PLC (Tumor subtype)
was_more_frequently
Object: grade_III (Tumor grade)
Original: PLC#was more frequently#grade III/ estrogen receptor negative/ and had Ki-67 greater than 10% compared with classic ILC
🏥 Prognostic significance 📄 PMID: 22197540
#15534 middle Confidence
Subject: Partial_tumor_regression (Changes in tumor phenotype)
occurs_after
Object: systemic_neoadjuvant_chemotherapy (Treatment options)
Original: Partial tumor regression#occurs after#systemic neoadjuvant chemotherapy
🏥 Treatment response 📄 PMID: 9410634
#15533 middle Confidence
Subject: MASC (Tumor type)
is_distinguished_by
Object: immunohistochemical_profile (Molecular characteristics)
Original: MASCs#are distinguished by#specific histopathological features and immunohistochemical profile
🏥 diagnosis 📄 PMID: 26517645